Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Willow Biosciences Inc. (C:WLLW)

Business Focus: Biopharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for WLLW within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Nov 12, 2020 20:36 ET
Willow Biosciences Reports Third Quarter 2020 Results and Operational Update
CALGARY, AB, Nov. 12, 2020 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF) has released its financial and operating results for the three and nine months ended September 30, 2020, reporting significant advancement in its operations and strong liquidity....
Read full article
Nov 12, 2020 20:36 ET
Willow Biosciences Reports Third Quarter 2020 Results and Operational Update
CALGARY, AB, Nov. 12, 2020 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF) has released its financial and operating results for the three and nine months ended September 30, 2020, reporting significant advancement in its operations and strong liquidity.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.50
--
--
Price to Sales - TTM
23,736.79
10.96
9.63
Price to Book - most recent quarter
12.61
10.03
3.14
Price to Cash Flow per share - TTM
--
--
11.60
Price to Free Cash Flow per share - TTM
--
--
17.74
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 196900
Dec 31, 196900
Dec 31, 196900
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Willow Biosciences Inc., formerly Makena Resources Inc., is a Canada-based research and development company. The Company is focused on creating synthetic biology solution from gene discovery to cannabinoid commercialization.

See business summary

 

Twitter

Search (past week) for $WLLW.CA

  • No tweets found